High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder

Clinical trial NCT00297947 · COMPLETED

Trial details

NCT number: NCT00297947
Sponsor: Manhattan Psychiatric Center
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2004-12-01
Primary completion: 2014-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.